News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website

 

Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival

Al's Comment:

 Although it was only a small phase 1 trial, they reported that the overall survival doubled compared to historical controls.  This is now in a large phase 2/3 trial throughout the USA.  We are working on raising funds to help speed up the approval process so all brain tumor patients could get access.  Eventually, this may work for not only brain but most other types of cancer. 


Posted on: 07/23/2016

Local Biotech Company Develops Therapy to Treat Brain Cancer for Extended Survival

 


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740